Feature | Angiography | July 15, 2016| Dave Fornell

10 Reasons Why You Need Supplemental Imaging in the Cath Lab

What angiography cannot see - reasons to use IVUS and OCT


A 3-D OCT rendering of a stented vessel segment created on St. Jude Medical's Ilumien Optis OCT system. 

A comparison IVUS, angiography, histology

A comparison of angiographic imaging (left), IVUS (center) and enhanced IVUS Virtual Histology using Volcano's IVUS system of the same vessel segement. 

rotational angiography

An example of a GE system used to create a rotational angiography 3-D rendering (in green) of the left atrium and left atrial appendage (LAA) overlaid on live fluoro. The overlay was used to help guide a transcatheter LAA occlusion procedure in an EP lab.

While angiographic X-ray fluoroscopy systems are the workhorse for transcatheter cardiovascular interventional procedures, the technology has several limitations that may impact not only procedural guidance, but also patient outcomes. When there is a clinical question that angiography alone cannot answer, that is when intravascular imaging techniques such as intravascular ultrasound (IVUS), optical coherence tomography (OCT) or rotational angiography should be used.

Ziad Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyterian Hospital, explained the limitations of angiography at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.

He said angiography limitations include:

1. Cannot determine plaque composition or presence of thin cap fibrous atheromas

2. Cannot image plaque ruptures

3. Cannot image stent malapposition

4. Unable to visualize distal edge of dissections

5. Difficult to visualize mid-segment minimal diameter

6. Difficult to estimate extent of stenosis due to positive remodeling

7. Difficult to properly assess bifurcation lesions due to additional muscle tissue

8. Difficult to do reference vessel sizing

9. Difficult to detect post-PCI complications

10. Difficult to gauge full extent of plaque burden since angiography only shows one 2-D view of a vessel, while OCT and IVUS can offer the entire cross-section of a vessel.


“Ideally it would be great to have a simple tool to do everything, like a Swiss army knife for interventional cardiology, but this is the real world and we don’t have this. So, you need to choose the most appropriate tool for the question you are asking,” Ali said. “The choice of imaging modality is dependent on the type of lesion you are assessing.”

Ali is an advocate for OCT because of its high-resolution image quality, instead of the grainy appearance of lower-resolution IVUS images. “It removes the ambiguity of scrolling through the vessel to look for problems,” he explained.

Watch the video "Advances in Intravascular Imaging at TCT 2015"  Ali explains recent advances in IVUS, OCT and FFR. This was a big topic discussed at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.


Navigation Enhanced by Rotational 3-D Angiography

Most of the advanced, premium angiography systems today offer rotational angiography. With this technology, the C-arm makes a quick sweep and is able to use the X-ray volume data to create computed tomography (CT)-like image reconstructions. This allows for the creation of 3-D soft tissue anatomy, which can be overlaid on live fluoro to aid navigation of the cardiac anatomy.  

While these 3-D images can aid in navigating catheters in vessels, their greatest benefit may be for navigation during transcatheter structural heart interventions, where it is very important to visualize soft tissue structures that are visible on fluoro.

Related Content

Treatment of Heart Attack Patients Depends on Cancer History
News | Cardio-oncology| September 26, 2017
Treatment of heart attack patients depends on their history of cancer, according to research published recently in...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init